95 results
8-K
EX-99.1
HZNP
Horizon Therapeutics Public Ltd Co
8 Aug 23
Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results
7:11am
by the United States Federal Trade Commission (the “FTC”) and subsequent lawsuit seeking to enjoin the transaction, manufacturing facility start-up costs … with the transaction with Amgen. The legal costs include costs incurred in responding to the FTC’s second request and subsequent lawsuit seeking to enjoin
8-K
EX-2.1
HZNP
Horizon Therapeutics Public Ltd Co
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
Non-U.S. Jurisdiction so as to obtain such Clearances under the HSR Act or other Antitrust Laws, and to avoid the commencement of a lawsuit by the FTC
8-K
EX-99.1
m4a6srbcdfg68joywqh3
12 Dec 22
This Announcement Is Being Made Pursuant to Rule 2.7 of the Irish Takeover Rules
7:39am
DEFA14A
eiy5rnovv6mqdir
12 Dec 22
Additional proxy soliciting materials
6:31am
8-K
EX-99.1
6lh42xoyy qn
29 Apr 22
Departure of Directors or Certain Officers
7:22pm